Preliminary Program.

 
 
8:30AM PROF SIR RICHARD FEACHEM University of California San Francisco
Challenges of malaria eradication
Chair: A/ Prof Helen Evans, Nossal Institute for Global Health and Burnet Institute

9:00AM DR RIMA SHRETTA University of California San Francisco and Asia Pacific Leaders Malaria Alliance
Economic case & political will

9:30AM PLENARY
The shifting landscape for financing health

10:00AM MORNING TEA & NETWORKING

10:30AM CONCURRENT 5

Innovative approaches to supporting affected persons voices to the table Partnering for strong malaria control and research Challenges of implementing new tools Accelerating malaria research & development through international collaborations (Sponsored by BVGH and WIPO) The future of health financing Plasmodium vivax treatment, risks and radical cure Genomics and malaria/transmission Diagnostics










Chair: Ms Patricia Kelly,
Director General, IP Australia


Chair: Dr Helen Saxenian,
Results for Development


Chair:Prof Ric Price
Menzies School of Health Research


Chair: Prof Dyann Wirth,
Harvard T.H. Chan School of Public Health






Prof Kevin Marsh
Developing health research and health workforce capacity

New technology for mapping and intervention
Mr Charles Randolph
Introduction of World Intellectual Property Organisation and WIPO Re:Search
Dr Helen Saxenian
*Details will be published shortly
Prof Dyann Wirth
Dr Jane Cunningham



Social innovation and entrepreneurship
Ms Patricia Kelly
Introduction to IP Australia, the Australia government's global health vision, and the Australian FIT program
Aparnaa Somanathan


Dr Gonzalo Domingo



Implementation of real-time genomic surveillance
Dr Cathy Manner
Introduction to FIT2 program, speakers, and session goal
Dr Rima Shretta
Transitions from donor financing & challenges for malaria elimination

Prof Karen Day
Dr Sabine Dittrich
Christiaan de Jager*
Innovation, education, communication and health promotion towards malaria elimination

Erin Nunan
Dr Rintis Noviyanti
Present research, FIT2 experience and skills learned, future plans post-sabbatical, and collaboration best practices - A Fellow perspective



Open for abstracts
Leticia Gallardo Estrella*
MOMALA-app: a smartphone based diagnostic tool for malaria
John Ede*
Treating malaria through health technology to "cut out" rural communities in Nigeria


Dr Alyssa Barry
Present research, FIT2 experience and skills learned, future plans post-sabbatical, and collaboration best practices - A Host's perspective



Md. Shafiul Alam*
Field evaluation of point of care assays for quantifying Glucose-6-Phosphate Dehydrogenase activity
Ademola Adelekan*
The ugly, the bad and the success of 2017 World Malaria Day commemoration at Orantan Community Ibadan Nigeria


Dr Deus Ishengoma
Present research, FIT2 experience and skills learned, future plans post-sabbatical, and collaboration best practices - A Fellow perspective



Leandra Arndt*
Novel magneto-optical method for malaria shows sustained potential in field tests in Papua New Guinea and Thailand

Q&A Panel



Panel Discussion: Discuss the challenges of R&D in low-resource settings, the value of partnering with research institutes in malaria-endemic countries, and how to establish mutually-beneficial research collaborations.





12:30PM LUNCH & NETWORKING

1:30PM CONCURRENT 6

Universal Access: Providing services to people where rountine services do not reach Maintaining momentum & strategies for the last mile: Elimination/Eradication lessons learnt Investing in new tools and technologies: Challenges for elimination & eradication Challenges to malaria eradication & how can we meet them? Unique challenges of non-falciparum malarias Recent advances in severe pathophysiology and treatment Surveillance










Chair: Dr Ingrid Chen
University of California, San Francisco


Chair: Prof Ivo Mueller
Walter and Eliza Hall Institute of Medical


Chair: Prof Arjen Dondorp,
Mahidol-Oxford Tropical Medicine Research Unit


Chair: Prof Sir Brian Greenwood,
London School of Hygiene and Tropical Medicine



Community level barriers to access

Malaria elimination efforts in Sri Lanka
*Details will be published shortly
Dr Winnie Mpanju-Shumbusho
Dr Jetsumon Prachumsri
Dr Haruhiko Isioka
Fluid resuscitation in adult severe malaria: how dry can you go?
Prof Sir Brian Greenwood

Supporting volunteers in disease elimination: Lessons learnt from GMS. The role of volunteers in communities; Pressures to integrate at community level; how to sustain community involvement when cases are negligible; Communities and health promotion; role of volunteers

LF, Drucunculiasis, other NTD elimination success stories

Balbir Singh
Prof Ric Price
Dr Katherine Plewes
Protecting the kidney with paracetamol in severe falciparum malaria
Prof Azra Ghani


Malaria in Africa comparison to other diseases eg polio

Prof Peter Gething
Prof Nicholas Anstey
Dr Bridget Barber
The free haemoglobin, oxidative stress, acute kidney injury, pathway in knowlesi malaria
Prof Archie Clements
Md Akramul Islam*
Scaling up health workforce in hard to reach areas of Chittagong: contributing to reduce severe malaria in Bangladesh

Priorities for maintaining momentum

Jim Tulloch
Dr Sarah Auburn
Prof Nicholas Anstey
Concomitant bacteraemia in adult severe malaria
Julie Simpson*
Influence of antenatal malaria screening in an area of low transmission on birthweight-for-gestational age
William Brieger*
Mapping to adapt mass drug administration of ivermectin for lymphatic filariasis and onchercerciasis to malaria vector control




Dr Stije Leopold
Contributors to metabolic acidosis in falciparum malaria
Verena Carrarra*
Surveillance of malaria in pregnancy and monitoring the effectiveness of malaria elimination
Aung Pyae Linn*
Performance of village health volunteers regarding malaria control activities in Myanmar





Philippe Boeuf*
A novel point-of-contact test for malaria serosurveillance
Q&Panel






3:00PM AFTERNOON TEA & NETWORKING

3:30PM PROF LENORE MANDERSON Monash University
Social movements and community engagements
Chair: Prof Maxine Whittaker, James Cook University

4:00PM PROF MARCEL TANNER Drugs for Neglected Diseases initiative (DNDi)

Chair: Prof Maxine Whittaker, James Cook University

4:30PM PANEL DISCUSSION

GALA EVENT
 

* Speakers are from selected abstracts therefore biography may not be available.